PERNIX THERAPEUTICS HOLDINGS, INC. - FORM 10-K - EX-23.1 - CONSENT - March 28, 2017

Attached files

file filename
EX-10.3 - AMENDED AND RESTATED GOLF TRUST OF AMERICA, INC. 2007 STOCK OPTION PLAN - PERNIX THERAPEUTICS HOLDINGS, INC.exh10-3.htm
EX-32.1 - 906 CERTIFICATE - PERNIX THERAPEUTICS HOLDINGS, INC.exh32-1.htm
EX-31.2 - CFO 302 CERTIFICATE - PERNIX THERAPEUTICS HOLDINGS, INC.exh31-2.htm
EX-31.1 - CEO 302 CERTIFICATE - PERNIX THERAPEUTICS HOLDINGS, INC.exh31-1.htm
EX-21.1 - SUBSIDIARIES - PERNIX THERAPEUTICS HOLDINGS, INC.exh21-1.htm
EX-10.35 - RESTRICTED SHARE UNIT AGREEMENT UNDER THE AMENDED AND RESTATED PERNIX THERAPEUTI - PERNIX THERAPEUTICS HOLDINGS, INC.exh10-35.htm
EX-10.34 - FORM OF NONQUALIFIED STOCK OPTION AGREEMENT UNDER THE AMENDED AND RESTATED - PERNIX THERAPEUTICS HOLDINGS, INC.exh10-34.htm
EX-10.33 - FORM OF NONQUALIFIED STOCK OPTION AGREEMENT UNDER THE AMENDED AND RESTATED - PERNIX THERAPEUTICS HOLDINGS, INC.exh10-33.htm
EX-10.32 - OFFER LETTER, DATED DECEMBER 16, 2016, BY AND BETWEEN PERNIX THERAPEUTICS HOLDIN - PERNIX THERAPEUTICS HOLDINGS, INC.exh10-32.htm
EX-10.30 - FORM OF INDEMNIFICATION AGREEMENT BETWEEN PERNIX THERAPEUTICS HOLDINGS, INC. AND - PERNIX THERAPEUTICS HOLDINGS, INC.exh10-30.htm
EX-10.17 - AMENDED AND RESTATED PERNIX THERAPEUTICS HOLDINGS, INC. 2015 OMNIBUS INCENTIVE P - PERNIX THERAPEUTICS HOLDINGS, INC.exh10-17.htm
EX-10.2 - AMENDED AND RESTATED 2010 EMPLOYEE STOCK PURCHASE PLAN - PERNIX THERAPEUTICS HOLDINGS, INC.exh10-2.htm
EX-10.1 - AMENDED AND RESTATED 2009 STOCK INCENTIVE PLAN - PERNIX THERAPEUTICS HOLDINGS, INC.exh10-1.htm
10-K - 10-K - PERNIX THERAPEUTICS HOLDINGS, INC.body10k.htm

EXHIBIT 23.1

Consent of Independent Registered Public Accounting Firm

We hereby consent to the incorporation by reference in the Registration Statements on Forms S-8 (No. 333-168877, No. 333-167327, No. 333-166062, No. 333-175992, No. 333-204997, and No. 333-210852), Form S-4 (No. 333-200042) and Forms S-3 (No. 333-186048, No. 333-174629, No. 333-200005, and No. 333-200011) of Pernix Therapeutics Holdings, Inc. of our report dated March 28, 2017 relating to the consolidated balance sheets of the Company as of December 31, 2016 and 2015, and the related consolidated statements of operations, comprehensive loss, stockholders' equity, and cash flows and the related consolidated statement schedule for each of the two years in the period ending December 31, 2016.

/s/ Cherry Bekaert LLP

Atlanta, Georgia
March 28, 2017

 

PERNIX THERAPEUTICS HOLDINGS, INC. Reports